Literature DB >> 22318482

[Characteristics of university students using stimulants for cognitive enhancement: a pilot study].

Andreas G Franke1, Cornelia E Schwarze, Michaela Christmann, Caroline Bonertz, Elisabeth Hildt, Klaus Lieb.   

Abstract

OBJECTIVE: Little is known regarding characteristics of subjects using substances exclusively for the purpose of pharmacological neuroenhancement (PN). Aim of this pilot study was to characterize students in Germany who use methylphenidate (MPH) and/or amphetamines (AMPH) for PN.
METHODS: Semi-structured interviews among 20 students who reported the use of MPH/AMPH for PN and 20 matched controls.
RESULTS: Subjects using stimulants for PN had significant better knowledge about further illicit substances for PN than controls. Users of AMPH more frequently used further illicit substances for PN than MPH users. Regarding prescription substances for PN no difference was found between MPH and AMPH users. AMPH users predominantly used AMPH intranasally for PN purposes. Stimulant users for PN used illicit substances (not for PN) more frequently with significantly higher rates of diagnoses of substance misuse of alcohol and THC (no difference between AMPH and MPH users).
CONCLUSIONS: Larger epidemiological studies are needed to elucidate the risk of misuse and addiction in subjects using stimulants for PN. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22318482     DOI: 10.1055/s-0031-1298900

Source DB:  PubMed          Journal:  Psychiatr Prax        ISSN: 0303-4259


  8 in total

1.  What users think about the differences between caffeine and illicit/prescription stimulants for cognitive enhancement.

Authors:  Andreas G Franke; Klaus Lieb; Elisabeth Hildt
Journal:  PLoS One       Date:  2012-06-29       Impact factor: 3.240

2.  Reflections on Addiction in Students Using Stimulants for Neuroenhancement: A Preliminary Interview Study.

Authors:  Elisabeth Hildt; Klaus Lieb; Christiana Bagusat; Andreas G Franke
Journal:  Biomed Res Int       Date:  2015-05-03       Impact factor: 3.411

3.  Life context of pharmacological academic performance enhancement among university students--a qualitative approach.

Authors:  Elisabeth Hildt; Klaus Lieb; Andreas Günter Franke
Journal:  BMC Med Ethics       Date:  2014-03-07       Impact factor: 2.652

4.  Pharmacological Neuroenhancement: teachers' knowledge and attitudes-Results from a survey study among teachers in Germany.

Authors:  Andreas G Franke; Sophie Lehmberg; Michael Soyka
Journal:  Subst Abuse Treat Prev Policy       Date:  2016-09-20

5.  Psychiatric Comorbidity and Stress in Medical Students Using Neuroenhancers.

Authors:  Tarek Jebrini; Kirsi Manz; Gabriele Koller; Daniela Krause; Michael Soyka; Andreas G Franke
Journal:  Front Psychiatry       Date:  2021-12-16       Impact factor: 4.157

6.  To dope or not to dope: neuroenhancement with prescription drugs and drugs of abuse among Swiss university students.

Authors:  Larissa J Maier; Matthias E Liechti; Fiona Herzig; Michael P Schaub
Journal:  PLoS One       Date:  2013-11-13       Impact factor: 3.240

7.  Towards a Moral Ecology of Pharmacological Cognitive Enhancement in British Universities.

Authors:  Meghana Kasturi Vagwala; Aude Bicquelet; Gabija Didziokaite; Ross Coomber; Oonagh Corrigan; Ilina Singh
Journal:  Neuroethics       Date:  2017-07-06       Impact factor: 1.480

8.  Pharmacological neuroenhancement and the ability to recover from stress - a representative cross-sectional survey among the German population.

Authors:  Christiana Bagusat; Angela Kunzler; Jennifer Schlecht; Andreas G Franke; Andrea Chmitorz; Klaus Lieb
Journal:  Subst Abuse Treat Prev Policy       Date:  2018-10-22
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.